| 米氮平与多塞平治疗躯体化障碍的对照研究 |
| |
| 引用本文： | 熊日先.米氮平与多塞平治疗躯体化障碍的对照研究[J].中国民康医学,2011,23(24):3023+3037. |
| |
| 作者姓名： | 熊日先 |
| |
| 作者单位： | 桂林市精神卫生中心、桂林市社会福利医院,广西桂林,541001 |
| |
| 摘 要： | 目的:观察米氮平对躯体化障碍的疗效和副反应。方法:将60例躯体化障碍患者随机分成米氮平组和多塞平组,治疗8周,用症状自评量表(SCL-90)、临床疗效大体评定量表(CGI)评定疗效,用副反应量表(TESS)评价副反应。结果:治疗8周后,米氮平和多塞平组的疗效相当,米氮平组比多塞平起效快、副反应较小。结论:米氮平治疗躯体化障碍疗效确切,起效快,副反应小,可作为躯体化障碍治疗的首选药物之一。
|
| 关 键 词： | 米氮平 躯体化障碍 多塞平 |
A controlled study of Mintazapine and Doxepin in the treatment of somatization disorder |
| |
| XIONG Ri-xian.A controlled study of Mintazapine and Doxepin in the treatment of somatization disorder[J].medical journal of chinese peoples health,2011,23(24):3023+3037. |
| |
| Authors: | XIONG Ri-xian |
| |
| Institution: | XIONG Ri-xian(Gulin Mental Health Center,Guilin Social Welfare Hospital,Gulin 541001,China) |
| |
| Abstract: | Objective:To assess the efficacy and advense effects of Mintazapine in the treatment of sometization disorder.Methods:Sixty patients with sometization disorder were randomly divided into two groups with Mirtazapine or Doxepin for 8 weeks.Symptom checklist 90(SCL-90) and clinical global impression(CGI) were used to assess the efficacy.Treatment emergent symptom scale(TESS) was used to assess adverse effects.Results:Affter 8 weeks,Mintazapine and Doxepin had similar therapeutic efficacy,but Mintazapine showed... |
| |
| Keywords: | Mirtazapine Somatization disorder Doxepin |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
